Annual SG&A
$105.44M$2.08M+2.02%
Summary
- Current Value
- As of today, DNLI annual SG&A is $105.44M, up +2.02% on
- Historical Performance
- DNLI annual SG&A is up +33.37% over the past 3 years, and up +126.85% over the past 5 years
- All-Time High Comparison
- DNLI annual SG&A is currently at its all-time high
- 3-Year Low Comparison
- DNLI annual SG&A is +16.54% above its 3-year low of $90.48M reached on an earlier date
- Sector Comparison
- DNLI annual SG&A is higher than 83.18% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $105.44M | +2.0% | +33.4% | +126.8% | +1964.2% | |
| Quarterly SG&A | $35.48M | +42.2% | +52.6% | +124.5% | +1039.9% | |
| TTM SG&A | -$6.93B | -7019.7% | -7911.3% | -10000.0% | -10000.0% | |
| Price | $16.95 | -20.0% | -41.3% | -77.1% | – | |
| Annual Operating Expenses | $501.88M | -4.8% | +45.7% | +109.2% | +2909.0% | |
| Annual Operating Profit | -$501.88M | -155.2% | -69.7% | -135.4% | -2909.0% | |
| Annual D&A | $8.99M | -46.2% | +4.6% | +12.5% | +7331.4% | |
| Annual Revenue | $0.00 | -100.0% | -100.0% | -100.0% | 0.0% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $105.44M | at high | |
| 5Y | $105.44M | at high | |
| All | $105.44M | at high |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $90.48M | N/A | +16.5% |
| 5Y | $60.33M | N/A | +74.8% |
| All | $5.11M | +1964.2% |
SG&A History
| Year | Value | Change |
|---|---|---|
| $105.44M | +2.0% | |
| $103.35M | +14.2% | |
| $90.48M | +14.4% | |
| $79.06M | +31.1% | |
| $60.33M | +29.8% |
| Year | Value | Change |
|---|---|---|
| $46.48M | +43.7% | |
| $32.35M | +106.3% | |
| $15.68M | +33.7% | |
| $11.73M | +129.7% | |
| $5.11M | - |
FAQ
What is the current annual SG&A of DNLI?
As of today, DNLI annual SG&A is $105.44M
What is 1-year change in DNLI annual SG&A?
DNLI annual SG&A is up +2.02% year-over-year
What is 3-year change in DNLI annual SG&A?
DNLI annual SG&A is up +33.37% over the past 3 years
How far is DNLI annual SG&A from its all-time high?
DNLI annual SG&A is currently at its all-time high
How does DNLI annual SG&A rank versus sector peers?
DNLI annual SG&A is higher than 83.18% of companies in Healthcare sector
When is DNLI next annual earnings release?
The next annual earnings release for DNLI is on
Quarterly SG&A
$35.48M$3.22M+9.97%
Summary
- Current Value
- As of today, DNLI quarterly SG&A is $35.48M, up +9.97% on
- Historical Performance
- DNLI quarterly SG&A is up +42.23% year-over-year, and up +52.56% over the past 3 years
- All-Time High Comparison
- DNLI quarterly SG&A is currently at its all-time high
- 3-Year Low Comparison
- DNLI quarterly SG&A is +50.89% above its 3-year low of $23.52M reached on an earlier date
- Sector Comparison
- DNLI quarterly SG&A is higher than 83.16% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $35.48M | +10.0% | +42.2% | +52.6% | +124.5% | |
| Annual SG&A | $105.44M | – | +2.0% | +33.4% | +126.8% | |
| TTM SG&A | -$6.93B | -6042.0% | -7019.7% | -7911.3% | -10000.0% | |
| Price | $16.95 | +13.8% | -20.0% | -41.3% | -77.1% | |
| Quarterly Operating Expenses | $134.49M | +1.9% | +10.8% | +22.5% | +123.7% | |
| Quarterly Operating Profit | -$137.43M | -1.8% | -11.6% | -27.9% | -128.6% | |
| Quarterly D&A | $2.95M | -3.2% | +60.3% | +131.0% | +505.1% | |
| Quarterly Revenue | $0.00 | 0.0% | 0.0% | -100.0% | -100.0% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $35.48M | at high | |
| 3Y | $35.48M | at high | |
| 5Y | $35.48M | at high | |
| All | $35.48M | at high |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $29.35M | +20.9% | |
| 3Y | $23.52M | N/A | +50.9% |
| 5Y | $17.99M | N/A | +97.2% |
| All | $3.05M | +1064.9% |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of DNLI?
As of today, DNLI quarterly SG&A is $35.48M
What is DNLI quarterly SG&A most recent change?
DNLI quarterly SG&A was up +9.97% on September 30, 2025
What is 1-year change in DNLI quarterly SG&A?
DNLI quarterly SG&A is up +42.23% year-over-year
How far is DNLI quarterly SG&A from its all-time high?
DNLI quarterly SG&A is currently at its all-time high
How does DNLI quarterly SG&A rank versus sector peers?
DNLI quarterly SG&A is higher than 83.16% of companies in Healthcare sector
When is DNLI next earnings release?
The next earnings release for DNLI is on
TTM SG&A
-$6.93B$498.74M-7.76%
Summary
- Current Value
- As of today, DNLI TTM SG&A is -$6.93B, down -7.76% on
- Historical Performance
- DNLI TTM SG&A is down -7019.74% year-over-year, and down -7911.25% over the past 3 years
- All-Time High Comparison
- DNLI TTM SG&A is currently -6594.86% below its historical high of -$103.51M set on an earlier date
- 3-Year Low Comparison
- DNLI TTM SG&A is at its 3-year low
- Sector Comparison
- DNLI TTM SG&A is higher than 5.36% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | -$6.93B | -6042.0% | -7019.7% | -7911.3% | -10000.0% | |
| Annual SG&A | $105.44M | – | +2.0% | +33.4% | +126.8% | |
| Quarterly SG&A | $35.48M | +10.0% | +42.2% | +52.6% | +124.5% | |
| Price | $16.95 | +13.8% | -20.0% | -41.3% | -77.1% | |
| TTM Operating Profit | -$547.82M | -2.7% | -8.6% | -75.3% | -129.1% | |
| TTM D&A | $10.17M | +12.2% | +25.3% | +98.8% | +49.6% | |
| TTM Revenue | $0.00 | 0.0% | 0.0% | -100.0% | -100.0% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$5.50B | N/A | -26.0% |
| 3Y | -$3.32B | N/A | -108.6% |
| 5Y | -$1.83B | N/A | -277.9% |
| All | -$103.51M | N/A | -6594.9% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$6.93B | N/A | at low |
| 3Y | -$6.93B | N/A | at low |
| 5Y | -$6.93B | N/A | at low |
| All | -$6.93B | N/A | at low |
TTM SG&A History
FAQ
What is the current TTM SG&A of DNLI?
As of today, DNLI TTM SG&A is -$6.93B
What is DNLI TTM SG&A most recent change?
DNLI TTM SG&A was down -7.76% on September 30, 2025
What is 1-year change in DNLI TTM SG&A?
DNLI TTM SG&A is down -7019.74% year-over-year
How does DNLI TTM SG&A rank versus sector peers?
DNLI TTM SG&A is higher than 5.36% of companies in Healthcare sector
When is DNLI next earnings release?
The next earnings release for DNLI is on
Selling, General & Administrative Expenses Formula
SG&A = − − R&D
Data Sources & References
- DNLI Official Website www.denalitherapeutics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1714899/000171489925000193/0001714899-25-000193-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1714899/000171489925000066/0001714899-25-000066-index.htm
- DNLI Profile on Yahoo Finance finance.yahoo.com/quote/DNLI
- DNLI Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dnli